 |
Request for Proposals: COVID-19 Research & Policy Team |
The Center for Antiracist Research is now accepting proposals from BU faculty for an R&P team related to COVID-19, in one of the following priority areas:
-
Racial and ethnic disparities, using or advancing data from the Center's COVID Racial Data Tracker, a collaboration with The Atlantic’s COVID Tracking Project
- Racial disparity in economic precarity during the COVID-19 pandemic
|
|
|
|
|
Non-Contact (and Socially Distanced) Vital Signs and Medical Measurement |
Register now to meet online with researchers from the four federally-funded Clinical and Translational Science programs in Massachusetts to hear about how they are working together to protect us from COVID-19.
|
|
|
|
New Funding Opportunities |
|
|
This competitive award program is designed to support 1-year innovative research projects contributed by postdoctoral fellows, staff scientists, and staff clinicians within the NIH IRP that have the potential for high impact in any area of minority health and health disparities research. Application Due Date: Monday, August 31, 2020 at 5 p.m. EDT.
|
The purpose of this funding opportunity is to focus on the role and impact of digital health interventions to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.
|
|
|
|
|
Due: Open
Funding: Not specified
Project period: Flexible, 1 to 3 years
Purpose: To address four areas of focus: future of evidence, future of social interaction, future of food, and future of work. Proposals may choose to focus on COVID-19, directly or indirectly, but a response to the pandemic is not required.
|
|
|
|
Due: Open
Funding: Not specified
Project Period: Not specified
Purpose: To support organizations responding directly to COVID-19 that also demonstrate how their intervention moves towards longer term adaptation and systemic/ sustainable impact beyond the immediate outbreak.
|
|
|
|
|
Due: October 30, 2020
Funding: $150,000
Project period: Two years
Purpose: The CIPHER Grant Programme supports the development of early-stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV in resource-limited settings.
|
|
|
|
Due: Rolling with monthly review
Funding: $5,000 to $150,000
Purpose: To support open source projects creatively responding to the COVID-19 pandemic. Includes but is not limited to software, hardware, firmware, design, and networking projects.
|
|
|
|
NIH-Funded Project Seeks to Identify Children
at Risk for MIS-C
|
Most children exposed to or infected with SARS-CoV-2, the virus that causes COVID-19, develop only a mild form of the illness. However, others go on to develop MIS-C(link is external), a severe, sometimes fatal, inflammation of organs and tissues, including the heart, lungs, kidneys, brain, skin and eyes.
|
|
|
NIH-Moderna Investigational COVID-19 Vaccine Shows Promise in Mouse Studies |
The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19.
|
|
|
NIH Launches Imaging AI Collaboration
for COVID-19 and Beyond
|
The National Institutes of Health is turning to artificial intelligence and imaging scans to not only help detect cases of COVID-19 earlier, but to potentially personalize treatments for the spreading disease.
|
|
|
NIH Clinical Trial to Test Antibodies and Other Experimental Therapeutics for Mild and
Moderate COVID-19
|
NIH launched ACTIV-2 (outpatient) & ACTIV-3 (inpatient) clinical trials to test monoclonal antibodies as a potential treatment for COVID-19.
|
|
|
NIH Clinical Trial Testing of Remdesivir Plus Interferon Beta-1a for COVID-19 Treatment Begins |
The study, called the Adaptive COVID-19 Treatment Trial 3 (ACTT 3), is anticipated to enroll more than 1,000 hospitalized adults with COVID-19 at as many as 100 sites in the United States and abroad.
|
|
|
Addressing the Twin Challenges of Substance Use Disorders and COVID-19 |
Drug overdoses and deaths are on the rise during COVID-19 pandemic. Learn more about the problem and possible solutions from NIH’s top expert on substance use disorders, Dr. Nora Volkow.
|
|
|
Lung Cancer Diagnosis and Patient Management During COVID-19 Pandemic |
Insights and best practices from experts for lung cancer diagnosis and workup during the
COVID-19 pandemic.
|
|
|
By studying data from a diverse group of people, researchers can learn more about what makes people sick or keeps them healthy. What researchers learn could lead to better treatment and disease prevention for all of us. To help speed up medical research, join the All of Us Research Program. |
|
|
the JAMA essay series that explains statistical techniques in clinical research to help clinicians interpret and critically appraise the medical literature.
|
|
|
|
Virtual Symposium to Advance the Response to COVID-19 |
The OMH virtual symposium aims to support the dissemination of promising practices, programs and strategies for combating COVID-19, especially in racial and ethnic minority communities.
|
|
|
|
|
NCATS Online Course in Translational Science - Sept. 8 – Oct. 23, 2020 |
Enhance your translational science skills this fall with a seven-week online course, MEDI 501: Principles of Preclinical Translational Science.
Registration for the fall course is open.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
